Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 3/20 | 0.69 |
| ▸ | FABP3 | P05413 | 2/20 | 0.69 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.34 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.34 |
| ▸ | MAP2K3 | P46734 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | EIF4A3 | P38919 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | RARG | P13631 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2383444 | 0.82 | FABP4 (0.69) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL810177 | 0.82 | FABP3 (1.00) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL8017724 | 0.80 | FABP4 (0.67) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL17311830 | 0.80 | FABP3 (0.96) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL14519841 | 0.80 | FABP4 (0.67) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL7484474 | 0.80 | FABP4 (0.67) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL17311829 | 0.78 | FABP4 (0.64) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL19245855 | 0.77 | FABP3 (0.62) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL5997548 | 0.77 | FABP4 (0.62) | FABP4FABP3FABP5GABRA1GABRB2 | |
| SCHEMBL10167825 | 0.77 | FABP3 (0.62) | FABP4FABP3FABP5GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3303353-B1 | PROCESS | JOHNSON MATTHEY PLC (GB) | 2022-01-12 | — | — | EP | disclosed |
| US-10428098-B2 | Processes for preparing and using ruthenium and osmium complexes | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2019-10-01 | — | — | US | disclosed |
| EP-2399895-B1 | Process for producing optically active aliphatic fluoroalcohol | KANTO KAGAKU (JP) | 2018-08-08 | — | — | EP | disclosed |
| US-20180148465-A1 | PROCESS | UNIVERSITA DEGLI STUDI DI UDINE (IT) | 2018-05-31 | — | — | US | disclosed |
| EP-3303353-A1 | PROCESS | Johnson Matthey Public Limited Company (GB) | 2018-04-11 | — | — | EP | disclosed |
| CN-107690436-A | Method of producing a composite material | 庄信万丰股份有限公司 | 2018-02-13 | — | — | CN | disclosed |
| US-9617292-B2 | Method for producing novel organometallic complex and amine compound | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2017-04-11 | — | — | US | disclosed |
| WO-2016193762-A1 | PROCESS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2016-12-08 | — | — | WO | disclosed |
| US-20160060282-A1 | METHOD FOR PRODUCING NOVEL ORGANOMETALLIC COMPLEX AND AMINE COMPOUND | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2016-03-03 | — | — | US | disclosed |
| EP-2990409-A1 | METHOD FOR PRODUCING NOVEL ORGANOMETALLIC COMPLEX AND AMINE COMPOUND | Kanto Kagaku Kabushiki Kaisha (JP) | 2016-03-02 | — | — | EP | disclosed |
| US-20100069683-A1 | Organic metal compound and process for preparing optically-active alcohols using the same | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20090216019-A1 | Process for Production of Optically Active Quinuclidinols | KANTO KAGAKU KABUSHIKI KAISHA | 2009-08-27 | — | — | US | disclosed |
| US-20090062573-A1 | Organic metal compound and process for preparing optically-active alcohols using the same | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2009-03-05 | — | — | US | disclosed |
| US-7378560-B2 | Ruthenium complex and process for producing tert-alkyl alcohol therewith | KANTO KANGAKU KABUSHIKI KAISHA (JP) | 2008-05-27 | — | — | US | disclosed |
| US-20080081911-A1 | Method for producing optically active quinuclidinols having one or more substituted groups at the 2-position | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2008-04-03 | — | — | US | disclosed |
| EP-1867654-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE QUINUCLIDINOL | Nagoya Industrial Science Research Institute (JP) | 2007-12-19 | — | — | EP | disclosed |
| US-20070265448-A1 | Ruthenium Complex and Process for Producing Tert-Alkyl Alcohol Therewith | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2007-11-15 | — | — | US | disclosed |
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | NAGOYA INDUSTRIAL SCIENCE RESEARCH CENTER (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1813621-A1 | RUTHENIUM COMPLEX AND PROCESS FOR PRODUCING TERT-ALKYL ALCOHOL THEREWITH | Nagoya Industrial Science Research Institute (JP) | 2007-08-01 | — | — | EP | disclosed |
| EP-1741693-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS | Nagoya Industrial Science Research Institute (JP) | 2007-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062573-A1 | Organic metal compound and process for preparing optically-active alcohols using the same | ADH1C, ADH1A, ADH5 | FABP4 3689/4885FABP3 4355/4885FABP5 1907/4885 |
| US-20080081911-A1 | Method for producing optically active quinuclidinols having one or more substituted groups at the 2-position | NQO1, SQLE, NQO2 | FABP4 4859/4885FABP3 4349/4885FABP5 4298/4885 |
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | ADH1C, ADH1A, ADH5 | FABP4 3743/4885FABP3 4252/4885FABP5 2213/4885 |
| US-20070265448-A1 | Ruthenium Complex and Process for Producing Tert-Alkyl Alcohol Therewith | TERT, ADH1C, ADH1A | FABP4 2819/4885FABP3 2698/4885FABP5 1276/4885 |
| US-20090216019-A1 | Process for Production of Optically Active Quinuclidinols | NQO2, ADH7, MRPL21 | FABP4 4279/4885FABP3 4173/4885FABP5 3459/4885 |
| US-10428098-B2 | Processes for preparing and using ruthenium and osmium complexes | OSTC, OTC, ORC3 | FABP4 2480/4885FABP3 3430/4885FABP5 771/4885 |
| US-20180148465-A1 | PROCESS | OSTC, AP2S1, LGALS4 | FABP4 1050/4885FABP3 2801/4885FABP5 195/4885 |
| US-20100069683-A1 | Organic metal compound and process for preparing optically-active alcohols using the same | ADH1C, ADH1A, ADH5 | FABP4 3689/4885FABP3 4355/4885FABP5 1907/4885 |
| US-20160060282-A1 | METHOD FOR PRODUCING NOVEL ORGANOMETALLIC COMPLEX AND AMINE COMPOUND | GNMT, HNMT, CYP4F11 | FABP4 4794/4885FABP3 4855/4885FABP5 4340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.